NEW YORK, June 12 - DeCode Genetics and Genmab said Tuesday they would collaborate in developing antibodies against DeCode's gene-based drug targets associated with cancer, cardiovascular, and inflammatory diseases.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
NPR reports that with medical data being big business, some companies want to get patients involved.
The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.
In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.
Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.